Tumor Treatment Drug Market Report

Global and Region Tumor Treatment Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：213
  • REPORT CODE：GMM1005859
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tumor Treatment Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tumor Treatment Drugmarket, defines the market attractiveness level of Tumor Treatment Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tumor Treatment Drug industry, describes the types of Tumor Treatment Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tumor Treatment Drug market and the development prospects and opportunities of Tumor Treatment Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tumor Treatment Drug market in Chapter 13.

    By Player:

    • Eli Lilly

    • Biogen Idec

    • Teva

    • Pfizer

    • Sanofi

    • Gilead Sciences

    • Bayer

    • Merck KGaA

    • AbbVie

    • Astellas

    • Takeda

    • Ipsen

    • Merck & Co

    • Roche

    • Novartis

    • Otsuka

    • Eisai

    • Johnson & Johnson

    • Bristol-Myers Squibb

    • Celgene

    • AstraZeneca

    • Amgen

    By Type:

    • Chemotherapy

    • Targeted Therapy

    • Immunotherapy (Biologic Therapy)

    • Hormonal Therapy

    • Others

    By End-User:

    • Blood Cancer

    • Breast Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Respiratory/Lung Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tumor Treatment Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tumor Treatment Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tumor Treatment Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tumor Treatment Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tumor Treatment Drug Market Analysis and Outlook to 2022

    • 7.1 Global Tumor Treatment Drug Consumption (2017-2022)

    • 7.2 United States Tumor Treatment Drug Consumption (2017-2022)

    • 7.3 Europe Tumor Treatment Drug Consumption (2017-2022)

    • 7.4 China Tumor Treatment Drug Consumption (2017-2022)

    • 7.5 Japan Tumor Treatment Drug Consumption (2017-2022)

    • 7.6 India Tumor Treatment Drug Consumption (2017-2022)

    • 7.7 South Korea Tumor Treatment Drug Consumption (2017-2022)

    8 Region and Country-wise Tumor Treatment Drug Market Analysis and Outlook to 2028

    • 8.1 Global Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.2 United States Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.4 China Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.6 India Tumor Treatment Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Tumor Treatment Drug Consumption Forecast (2022-2028)

    9 Global Tumor Treatment Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Tumor Treatment Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tumor Treatment Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Tumor Treatment Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Tumor Treatment Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tumor Treatment Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tumor Treatment Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tumor Treatment Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tumor Treatment Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tumor Treatment Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tumor Treatment Drug Market Competitive Analysis

    • 14.1 Eli Lilly

      • 14.1.1 Eli Lilly Company Details

      • 14.1.2 Eli Lilly Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly Tumor Treatment Drug Product and Service

    • 14.2 Biogen Idec

      • 14.2.1 Biogen Idec Company Details

      • 14.2.2 Biogen Idec Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Biogen Idec Tumor Treatment Drug Product and Service

    • 14.3 Teva

      • 14.3.1 Teva Company Details

      • 14.3.2 Teva Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Tumor Treatment Drug Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Tumor Treatment Drug Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Tumor Treatment Drug Product and Service

    • 14.6 Gilead Sciences

      • 14.6.1 Gilead Sciences Company Details

      • 14.6.2 Gilead Sciences Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gilead Sciences Tumor Treatment Drug Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Tumor Treatment Drug Product and Service

    • 14.8 Merck KGaA

      • 14.8.1 Merck KGaA Company Details

      • 14.8.2 Merck KGaA Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Merck KGaA Tumor Treatment Drug Product and Service

    • 14.9 AbbVie

      • 14.9.1 AbbVie Company Details

      • 14.9.2 AbbVie Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AbbVie Tumor Treatment Drug Product and Service

    • 14.10 Astellas

      • 14.10.1 Astellas Company Details

      • 14.10.2 Astellas Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Astellas Tumor Treatment Drug Product and Service

    • 14.11 Takeda

      • 14.11.1 Takeda Company Details

      • 14.11.2 Takeda Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Takeda Tumor Treatment Drug Product and Service

    • 14.12 Ipsen

      • 14.12.1 Ipsen Company Details

      • 14.12.2 Ipsen Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Ipsen Tumor Treatment Drug Product and Service

    • 14.13 Merck & Co

      • 14.13.1 Merck & Co Company Details

      • 14.13.2 Merck & Co Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Merck & Co Tumor Treatment Drug Product and Service

    • 14.14 Roche

      • 14.14.1 Roche Company Details

      • 14.14.2 Roche Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Roche Tumor Treatment Drug Product and Service

    • 14.15 Novartis

      • 14.15.1 Novartis Company Details

      • 14.15.2 Novartis Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis Tumor Treatment Drug Product and Service

    • 14.16 Otsuka

      • 14.16.1 Otsuka Company Details

      • 14.16.2 Otsuka Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Otsuka Tumor Treatment Drug Product and Service

    • 14.17 Eisai

      • 14.17.1 Eisai Company Details

      • 14.17.2 Eisai Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Eisai Tumor Treatment Drug Product and Service

    • 14.18 Johnson & Johnson

      • 14.18.1 Johnson & Johnson Company Details

      • 14.18.2 Johnson & Johnson Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Johnson & Johnson Tumor Treatment Drug Product and Service

    • 14.19 Bristol-Myers Squibb

      • 14.19.1 Bristol-Myers Squibb Company Details

      • 14.19.2 Bristol-Myers Squibb Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Bristol-Myers Squibb Tumor Treatment Drug Product and Service

    • 14.20 Celgene

      • 14.20.1 Celgene Company Details

      • 14.20.2 Celgene Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Celgene Tumor Treatment Drug Product and Service

    • 14.21 AstraZeneca

      • 14.21.1 AstraZeneca Company Details

      • 14.21.2 AstraZeneca Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 AstraZeneca Tumor Treatment Drug Product and Service

    • 14.22 Amgen

      • 14.22.1 Amgen Company Details

      • 14.22.2 Amgen Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Amgen Tumor Treatment Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tumor Treatment Drug

    • Figure Tumor Treatment Drug Picture

    • Table Global Tumor Treatment Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Treatment Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tumor Treatment Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tumor Treatment Drug Consumption by Country (2017-2022)

    • Figure United States Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Figure China Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Figure India Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tumor Treatment Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Treatment Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tumor Treatment Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory/Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respiratory/Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tumor Treatment Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tumor Treatment Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Tumor Treatment Drug Product and Service

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Tumor Treatment Drug Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Tumor Treatment Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Tumor Treatment Drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Tumor Treatment Drug Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Tumor Treatment Drug Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Tumor Treatment Drug Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Tumor Treatment Drug Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Tumor Treatment Drug Product and Service

    • Table Astellas (Foundation Year, Company Profile and etc.)

    • Table Astellas Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Tumor Treatment Drug Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Tumor Treatment Drug Product and Service

    • Table Ipsen (Foundation Year, Company Profile and etc.)

    • Table Ipsen Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen Tumor Treatment Drug Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Tumor Treatment Drug Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Tumor Treatment Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Tumor Treatment Drug Product and Service

    • Table Otsuka (Foundation Year, Company Profile and etc.)

    • Table Otsuka Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Tumor Treatment Drug Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Tumor Treatment Drug Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Tumor Treatment Drug Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Tumor Treatment Drug Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Tumor Treatment Drug Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Tumor Treatment Drug Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Tumor Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Tumor Treatment Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US